N. Moatti

发表

[Membrane phospholipid peroxidation in renal insufficiency and chronic hemodialysis].

J. Paul, N. Man, N. Moatti, 1991, Nephrologie.

Abnormalities of lipid metabolism and arterial rigidity in young subjects with borderline hypertension.

M. Safar, B. Pannier, M. Cambillau, 1994, Clinical and investigative medicine. Medecine clinique et experimentale.

A new DNA polymorphism in the 5' untranslated region of the human SREBP-1a is related to development of atherosclerosis in high cardiovascular risk population.

A. Simon, J. Mégnien, X. Jeunemaître, 2001, Atherosclerosis.

The Philadelphia variant of galactokinase in human erythrocytes: physicochemical and catalytic properties.

M. Brivet, N. Moatti, A. Lemonnier, 1988, Clinica chimica acta; international journal of clinical chemistry.

Enhanced modifications of low-density lipoproteins (LDL) by endothelial cells from smokers: a possible mechanism of smoking-related atherosclerosis.

N. Moatti, I. Myara, A. Proust, 1996, Cardiovascular research.

Serum lipid abnormalities in heart transplant recipients: predominance of HDL2-like particles in the HDL pattern.

A. Carpentier, D. Farge, M. Cambillau, 1990, Atherosclerosis.

Charge heterogeneity of LDL in asymptomatic hypercholesterolemic men is related to lipid parameters and variations in the ApoB and CIII genes.

A. Simon, J. Mégnien, X. Jeunemaître, 1998, Arteriosclerosis, thrombosis, and vascular biology.

Lipid Parameters and Variations in the ApoB and CIII Genes Charge Heterogeneity of LDL in Asymptomatic Hypercholesterolemic Men Is Related to

J. Mégnien, X. Jeunemaître, B. Vedie, 1998 .

Evaluation of the sialic acid content of LDL as a marker of coronary calcification and extracoronary atherosclerosis in asymptomatic hypercholesterolemic subjects. PCVMETRA Group.

A. Simon, J. Levenson, P. Giral, 1995, Arteriosclerosis, thrombosis, and vascular biology.

A Relationship between Aortic Stiffness and Serum HDL3 Cholesterol Concentrations in Hypercholesterolaemic, Symptom-Free Men

A. Simon, J. Mégnien, J. Levenson, 1994, Journal of cardiovascular risk.

Characterization of polymorphic structure of SREBP-2 gene: role in atherosclerosis.

A. Simon, J. Gariépy, G. Chironi, 2003, Atherosclerosis.

A cell culture system for screening human serum for ability to promote cellular cholesterol efflux. Relations between serum components and efflux, esterification, and transfer.

P. Giral, J. Paul, N. Fournier, 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

Endothelin and cardiovascular remodelling in end-stage renal disease.

J. Blacher, M. Safar, G. London, 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Analysis of the relationship between triglyceridemia and HDL-phospholipid concentrations: consequences on the efflux capacity of serum in the Fu5AH system.

A. Simon, P. Giral, J. Paul, 2001, Atherosclerosis.

Coronary Calcification andItsRelation to Extracoronary Atherosclerosis inAsymptomatic

A. Simon, A. Hernigou, J. Mégnien, 1992 .

Erythrocyte, but not plasma, vitamin E concentration is associated with carotid intima-media thickening in asymptomatic men at risk for cardiovascular disease.

A. Simon, J. Gariépy, J. Paul, 2001, Atherosclerosis.

Erythrocyte antioxidant status in asymptomatic hypercholesterolemic men.

A. Simon, J. Paul, N. Moatti, 1997, Atherosclerosis.

Prognostic value of cardiac markers in ESRD: Chronic Hemodialysis and New Cardiac Markers Evaluation (CHANCE) study.

P. Tuppin, N. Moatti, M. Iliou, 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Factors associated with increased serum levels of cardiac troponins T and I in chronic haemodialysis patients: Chronic Haemodialysis And New Cardiac Markers Evaluation (CHANCE) study.

P. Tuppin, N. Moatti, M. Iliou, 2001, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Cholesterol efflux potential of sera from mice expressing human cholesteryl ester transfer protein and/or human apolipoprotein AI.

A. Tall, A. Walsh, N. Moatti, 1995, The Journal of clinical investigation.

HDL phospholipid content and composition as a major factor determining cholesterol efflux capacity from Fu5AH cells to human serum.

J. Paul, N. Fournier, N. Moatti, 1997, Arteriosclerosis, thrombosis, and vascular biology.

Elevated high density lipoprotein concentrations in heart transplant recipients are related to impaired plasma cholesteryl ester transfer and hepatic lipase activity.

M. Cambillau, R. Guillemain, N. Moatti, 1993, Atherosclerosis.

Oxidative modification of low-density lipoprotein by the human hepatoma cell line HepG2.

B. Vedie, N. Moatti, I. Myara, 1996, Free radical research.

A method to screen for the antioxidant effect of compounds on low-density lipoprotein (LDL): illustration with flavonoids.

B. Vedie, N. Moatti, I. Myara, 1993, Journal of pharmacological and toxicological methods.

Influence of culture medium characteristics on the ability to oxidize low-density lipoproteins

N. Moatti, I. Myara, A. Caprani, 1993 .

I papers and notes on I methaEology Fractionation of charge-modified low density I i poprotei ns by fast protein liquid chromatography'

B. Vedie, J. Mazière, N. Moatti, 1991 .

Characteristics of ten charge-differing subfractions isolated from human native low-density lipoproteins (LDL). No evidence of peroxidative modifications.

J. Mazière, N. Moatti, I. Myara, 1995, Biochimica et biophysica acta.

Opposite Effects of Plasma From Human Apolipoprotein A-II Transgenic Mice on Cholesterol Efflux From J774 Macrophages and Fu5AH Hepatoma Cells

J. Paul, N. Fournier, N. Moatti, 2002, Arteriosclerosis, thrombosis, and vascular biology.

Opposite Effects of Plasma From Human ApoA-II Transgenic Mice on Cholesterol Efflux From J 774 Macrophages and Fu 5 AH Hepatoma Cells

J. Paul, N. Fournier, N. Moatti, 2002 .

Structural changes of high-density-lipoprotein apolipoproteins following incubation with human polymorphonuclear cells.

J. Paul, N. Moatti, V. Atger, 1994, European journal of biochemistry.

Fractional efflux and net change in cellular cholesterol content mediated by sera from mice expressing both human apolipoprotein AI and human lecithin:cholesterol acyltransferase genes.

N. Fournier, N. Moatti, V. Atger, 1999, Atherosclerosis.

Homocysteine decreases endothelin-1 expression by interfering with the AP-1 signaling pathway.

N. Moatti, S. Drunat, K. Demuth, 2002, Free radical biology & medicine.

Enhanced efflux of cholesterol from ABCA1-expressing macrophages to serum from type IV hypertriglyceridemic subjects.

J. Paul, N. Fournier, M. Cambillau, 2003, Atherosclerosis.

Dynamin is Involved in Endolysosomal Cholesterol Delivery to the Endoplasmic Reticulum: Role in Cholesterol Homeostasis

J. Paul, B. Vedie, C. Lamaze, 2006, Traffic.

A Study of Fibrinogen and Fibrinolysis in 10 Adults with Nephrotic Syndrome

J. Fiessinger, N. Moatti, M. Aiach, 1988, Thrombosis and Haemostasis.

Homocysteine-induced decrease in endothelin-1 production is initiated at the extracellular level and involves oxidative products.

J. Paul, N. Moatti, S. Drunat, 2001, European journal of biochemistry.

Association between plasma homocysteine concentrations and cardiac hypertrophy in end-stage renal disease.

J. Blacher, M. Safar, G. London, 1999, Journal of nephrology.

IgG subclass typing by immunofixation.

N. Moatti, I. Myara, H. Trébéden, 1997, Clinica chimica acta; international journal of clinical chemistry.

Plasma and erythrocyte vitamin E content in asymptomatic hypercholesterolemic subjects.

A. Simon, J. Paul, N. Moatti, 1997, Clinical chemistry.

Monoclonal and oligoclonal gammopathies in heart-transplant recipients.

R. Guillemain, N. Moatti, I. Myara, 1991, Clinical chemistry.

Study of vitamin E net mass transfer between alpha-tocopherol-enriched HDL and erythrocytes: application to asymptomatic hypercholesterolemic men.

A. Simon, J. Paul, N. Moatti, 2000, Free radical biology & medicine.

Respective effects of glucose and glutamine on the glutamine synthetase activity of human skin fibroblasts

M. Gautier, N. Moatti, C. Wolfrom, 1991, Molecular and Cellular Biochemistry.

Cholesterol efflux from Fu5AH cells to the serum of patients with Alagille syndrome. Importance of the hdl-phospholipids/free cholesterol ratio and of the hdl size distribution.

A. Legrand, M. Hadchouel, N. Moatti, 1999, Journal of lipid research.

Role of HDL phospholipid in efflux of cell cholesterol to whole serum: studies with human apoA-I transgenic rats.

N. Fournier, N. Moatti, V. Atger, 1996, Journal of lipid research.

d-glucose uptake in human liver cell cultures

M. Gautier, N. Moatti, A. Lemonnier, 1981, In Vitro.

Glycine transport by cultured skin fibroblasts from a patient with isolated hyperglycinuria

N. Moatti, J. Maccario, A. Lemonnier, 1980, Journal of Inherited Metabolic Disease.

IL‐1β, a strong mediator for glucose uptake by rheumatoid and non‐rheumatoid cultured human synoviocytes

A. Hernvann, O. Ekindjian, N. Moatti, 1992, FEBS letters.

Transport of L‐alanine in cultured human fibroblasts: Evidence for two kinetically distinguishable systems

N. Moatti, A. Lemonnier, F. Lemonnier, 1981, Journal of cellular physiology.

Susceptibility to copper oxidation of neuraminidase-treated LDL.

N. Moatti, M. Haberland, I. Myara, 1995, Clinica chimica acta; international journal of clinical chemistry.

Role of HDL phospholipid in to whole serum: studies with transgenic rats efflux of cell cholesterol human apoA-I

N. Fournier, N. Moatti, V. Atger, 1996 .

Human kidney prolidase--purification, preincubation properties and immunological reactivity.

N. Moatti, I. Myara, C. Cosson, 1994, The International journal of biochemistry.

A rare case of IgD gammopathy associated with free light-chain cryoglobulinemia and a gelling Bence Jones protein.

J. Rossert, N. Moatti, I. Myara, 1993, Clinica chimica acta; international journal of clinical chemistry.

Fractionation of charge-modified low density lipoproteins by fast protein liquid chromatography.

B. Vedie, J. Mazière, N. Moatti, 1991, Journal of lipid research.

Oxidative modification of high-density lipoprotein 3 induced by human polymorphonuclear neutrophils. Protective effect of pentoxifylline.

J. Paul, N. Moatti, V. Atger, 1999, European journal of biochemistry.

Plasma insulin, plasminogen activator inhibitor, and ankle-brachial systolic blood pressure ratio in overweight hypertensive subjects

M. Brahimi, M. Safar, A. Achimastos, 1999, Journal of Human Hypertension.

Type Ib glycogen storage disease: an in vivo and in vitro study of two cases.

M. Brivet, N. Moatti, C. Baussan, 1984, Journal of inherited metabolic disease.

Comparative study of extracellular amino acids in culture of human liver and fibroblastic cells

M. Gautier, N. Moatti, A. Lemonnier, 1976, In Vitro.

Amino acid transport systems in the human hepatoma cell line Hep G2.

N. Moatti, A. Lemonnier, T. Soni, 1992, Biochemical and biophysical research communications.

Transport ofl-histidine by human diploid fibroblasts in culture

N. Moatti, A. Lemonnier, A. Corriat, 1983, In Vitro.

Asymptomatic hyperamylasemia after cyclosporine therapy in patients with renal transplants.

N. Moatti, I. Myara, C. Cosson, 1988, Transplantation proceedings.

Blood lipids and rheological modifications in glycogen storage disease.

A. Simon, J. Levenson, A. Legrand, 1996, Clinical biochemistry.

Biochemical diagnosis of hepatic glycogen storage diseases: 20 years French experience.

N. Moatti, I. Maire, C. Baussan, 1991, Clinical biochemistry.

Glutamine dependency of human skin fibroblasts: modulation by hexoses.

M. Gautier, N. Moatti, G. Polini, 1989, Experimental cell research.

The Philadelphia variant of galactokinase: impaired [1-14C]galactose oxidation by intact erythrocytes.

M. Brivet, N. Moatti, A. Lemonnier, 1988, Clinica chimica acta; international journal of clinical chemistry.

Defective Galactose Oxidation in a Patient with Glycogen Storage Disease and Fanconi Syndrome

M. Brivet, N. Moatti, M. Odiévre, 1983, Pediatric Research.

Methemalbumin interference in various biochemical assays of plasma.

F. Trivin, N. Moatti, I. Myara, 1988, Clinical chemistry.

Influence of uremia on polymorphonuclear leukocytes oxidative metabolism in end-stage renal disease and dialyzed patients.

J. Paul, N. Man, N. Moatti, 1991, Nephron.

Influence of HDL subfractions on erythrocyte aggregation in hypercholesterolemic men. PCVMETRA Group.

A. Simon, J. Levenson, P. Giral, 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

Interleukin-1 beta and interleukin-6 stimulate 2-methylaminoisobutyric acid uptake in HepG2 cells.

A. Legrand, N. Moatti, C. Cosson, 1997, The international journal of biochemistry & cell biology.

Oxidative modifications of low-density lipoproteins (LDL) by the human endothelial cell line EA.hy 926

J. Mazière, N. Moatti, I. Myara, 1996, Experientia.

Lipid peroxidation abnormalities in hemodialyzed patients.

J. Paul, N. Man, N. Moatti, 1993, Nephron.

men. PCVMETRA Group Influence of HDL subfractions on erythrocyte aggregation in hypercholesterolemic

P. Giral, M. Cambillau, N. Moatti, 2011 .

The efflux of cholesterol from ABC1-expressing J774 macrophages is highest when exposed to serum from human apo AII transgenic mice

N. Fournier, N. Moatti, J. Chambaz, 2001 .

Human ApoA-IV overexpression in transgenic mice induces cAMP-stimulated cholesterol efflux from J774 macrophages to whole serum.

J. Paul, N. Fournier, N. Moatti, 2000, Arteriosclerosis, thrombosis, and vascular biology.

Homocysteine decreases endothelin-1 production by cultured human endothelial cells.

D. Borderie, S. Lotersztajn, N. Moatti, 1999, European journal of biochemistry.

Monoclonaland Oligoclonal Gammopathiesin Heart-TransplantRecipients

R. Guillemain, N. Moatti, I. Myara, 1991 .

[Vitamin E: metabolism and role in atherosclerosis].

J. Paul, N. Moatti, V. Atger, 1994, Annales de Biologie Clinique.

Reactivity of lecithin-cholesterol acyl transferase (LCAT) towards glycated high-density lipoproteins (HDL).

N. Fournier, N. Moatti, I. Myara, 1995, Clinica chimica acta; international journal of clinical chemistry.

Influence of biochemical alterations on arterial stiffness in patients with end-stage renal disease.

J. Blacher, M. Safar, G. London, 1998, Arteriosclerosis, thrombosis, and vascular biology.

Only prolidase I activity is present in human plasma.

N. Moatti, I. Myara, C. Cosson, 1992, The International journal of biochemistry.

Coronary Calcification and Its Relation to Extracoronary Atherosclerosis in Asymptomatic Hypercholesterolemic Men

A. Simon, A. Hernigou, J. Mégnien, 1992, Circulation.

Serum prolactin as a rejection marker in heart transplantation.

R. Guillemain, N. Moatti, G. Dreyfus, 1989, Clinical chemistry.

Opposite effects of plasma homocysteine and the methylenetetrahydrofolate reductase C677T mutation on carotid artery geometry in asymptomatic adults.

O. Hanon, M. Safar, X. Girerd, 1998, Arteriosclerosis, thrombosis, and vascular biology.

High-density lipoprotein subfractions as markers of early atherosclerosis

A. Simon, J. Gariépy, J. Mégnien, 1995 .

A cytotoxic electronegative LDL subfraction is present in human plasma.

B. Vedie, N. Moatti, M. Haberland, 1996, Arteriosclerosis, thrombosis, and vascular biology.

Use of platelets, mononuclear and polymorphonuclear cells in the diagnosis of glycogen storage disease type VI

N. Moatti, C. Baussan, A. Lemonnier, 1988, Journal of Inherited Metabolic Disease.

Liver glycogenosis caused by a defective phosphorylase system: hemolysate analysis.

N. Moatti, C. Baussan, M. Odiévre, 1981, Pediatrics.

L-proline uptake in human fibroblasts: evidence for a high-affinity system in addition to system A.

N. Moatti, J. Maccario, A. Lemonnier, 1987, Biochemical and biophysical research communications.

Evidence that cycloleucine affects the high-affinity systems of amino acid uptake in cultured human fibroblasts.

M. Gautier, N. Moatti, J. Maccario, 1984, Biochemical Journal.

Homocysteine is the only plasma thiol associated with carotid artery remodeling.

M. Safar, P. Boutouyrie, J. Paul, 2002, Atherosclerosis.

[Value of transgenic mouse as model for the study of human lipoprotein metabolism].

J. Paul, N. Fournier, N. Moatti, 1995, Annales de biologie clinique.

Decreased erythrocyte deformability in glycogen storage disease.

A. Simon, J. Levenson, A. Legrand, 1996, Thrombosis research.

Cardiac troponin I: Its contribution to the diagnosis of perioperative myocardial infarction and various complications of cardiac surgery

N. Moatti, M. Benoit, M. Paris, 2001, Critical care medicine.

[Genetic variation in the apolipoprotein B gene].

X. Jeunemaître, B. Vedie, N. Moatti, 1995, Annales de Genetique.

Abnormal lipoprotein pattern in patients with Alagille syndrome depends on Icterus severity.

A. Legrand, M. Cambillau, M. Hadchouel, 1996, Gastroenterology.

Inhibition of lecithin cholesterol acyltransferase by phosphatidylcholine hydroperoxides

N. Moatti, P. Thérond, A. Legrand, 1999, FEBS letters.

Usefulness of the kappa/lambda ratio for detecting a new monoclonal component in a patient with a monoclonal gammopathy.

N. Moatti, M. Asso, I. Myara, 1994, Clinica chimica acta; international journal of clinical chemistry.

Influence of lipoprotein subfractions on dextran- and fibrinogen-induced erythrocyte aggregation

A. Simon, J. Levenson, J. Paul, 1995 .